Abstract
Aortic valve replacement (AVR) is the established treatment for patients with symptomatic aortic stenosis. Left ventricular hypertrophy, a known manifestation of aortic stenosis, is associated with increased risk of sudden death, congestive heart failure, and stroke. The superior outcome after AVR is achieved with regression of left ventricular hypertrophy, known as left ventricular mass and indexed to body surface area.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Santini F, Bertolini P, Montlbano G, Vecchi B, Pessotto R, Prioli A, Mazzucco A (1998) Hancock versus stentless bioprostheses for aortic valve replacement in patients older than 75 year. Ann Thorac Surg 66:S99–S103
Williams RJ, Muir DF, Pathi V, MacArthur K, Berg GA (1999) Randomized controlled trial of stented and stentless aortic bioprostheses: hemodynamic performance at 3 years. Semin Thorac Cardiovasc Surg 4(Suppl 1):93–97
Cohen G, Christakis GT, Joyner CD, Morgan CD, Tamariz M, Hanayama N, Mallidi H, Szalai JP, Katic M, Rao V, Fremes SE, Goldman BS (2002) Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg 73:767–778
Doss M, Martens S, Wood JP, Aybek T, Kleine P, Wimmer Greinecker G, Moritz A (2003) Performance of stentless versus stented aortic valve bioprostheses in the elderly patients: a prospective randomized trial. Eur J Cardiothorac Surg 23:299–304
Sensky PR, Loubani M, Keal RP, Samani NJ, Sosnowski AW, Galinanes M (2003) Does the type of prosthesis influence early left ventricular mass regression afgter aortic valve replacement? Assessment with magnetic resonance imaging. Am Heart J 146:746
Totaro P, Degno N, Zaidi A, Youhana P, Argano V (2005) Carpentier-Edwards PERIMOUNT Magna bioprosthesis: A stented valve with stentless performance? J Thorac Cardiovasc Surg 130:1668–1674
Ali A, Halstead JC, Cafferty F, Sharples L, Rose F, Coulden R, Lee E, Dunning J, Argano V, Tsui S (2006) Are stentless valves superior to modern stented valves? A prospective randomized trial. Circulation 114[suppl I]:I-535–I-540
Perez de Arenaza D, Lees B, Flather M, Nugara F, Husebye T, Jasinski M, Cisowski M, Khan M, Henein M, Gaer J, Guvendik L, Bochenek A, Wos S, Lie M, Van Nooten G, Pennell D, Pepper J, on behalf of the ASSERT (Aortic Stentless versus Stented valve Assessed by Echocardiography Randomized Trial) (2005) Circulation 112:2696–2702
Chambers JB, Rimington HM, Hodson F, Rajani R, Blauth CI (2006) The subcoronary Toronto stentless versus supra-annular Perimount stented replacement aortic valve: early clinical and hemodynamic results of a randomized comparison in 160 patients. J Thorac Cardiovasc Surg 131:878–882
Dunning J, Graham RJ, Thambyrajah J, Stewart JM, Kendall SW, Hunter S (2007) Stentless vs stented aortic valve bioprostheses: a prospective randomized controlled trial. Eur Heart J 28:2369–2374
Lehman S, Walther T, Kempfert J, Leontjev S, Rastan A, Falk V, Mohr FW (2007) Stentless versus conventional xenograft aortic valve replacement: midterm results of a prospectively randomized trial. Ann Thorac Surg 84:467–472
Kunadian B, Vijayalakshmi K, Thornley AR, de Belder MA, Hunter S, Kendall S, Graham R, Stewart M, Thambyrajah J, Dunning J (2007) Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. Ann Thorac Surg 84:73–79
Maselli D, Pizio R, Bruno LP, Di Bella I, De Gasperis C (1999) Left ventricular mass reduction after aortic valve replacement: Homografts, stentless and stented valves. Ann Thorac Surg 67:966–971
Szafranek A, Jasinski M, Kolowca M, Gemel M, Wos S (2006) Plasma ANP and rennin-angiotensin-aldosterone system as new parameters describing the hemodynamics of the circulatory system after implantation of stented or stentelss aortic valves. J Heart Valve Dis 15:702–709
Miraldi F, Spagnesi L, Tallarico D, Di Matteo G, Brancaccio G (2007) Sorin stentless pericardial valve versus Carpentier-Edwards Perimount pericardial bioprosthesis: is it worthwhile to struggle? Int J Cardiol 118(2):253–255
Cheng D, Pepper J, Martin J, Stanbridge RDL, Ferdinand FD, Jamieson WRE, Berg G, Sani G (2009) Stentless versus stented bioprosthetic aortic valves: a systematic review and meta-analysis of controlled trials. Innovations 4:61–73
Pepper J, Cheng D, Stanbridge RDL, Ferdinand FD, Jamieson WRE, Stelzer P, Berg G, Sani G, Martin J (2009) Stentless versus stented bioprosthetic aortic valves: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS). Innovations 4:49–60
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jamieson, W.R.E. (2010). Stented and stentless aortic bioprostheses: competitive or complimentary?. In: Yankah, C.A., Weng, Y., Hetzer, R. (eds) Aortic Root Surgery. Steinkopff. https://doi.org/10.1007/978-3-7985-1869-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1869-8_23
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1868-1
Online ISBN: 978-3-7985-1869-8
eBook Packages: MedicineMedicine (R0)